Kimia Biosciences Ltd - Stock Valuation and Financial Performance

BSE: 530313 | NSE: | Pharmaceuticals & Drugs | Small Cap

Kimia Biosciences Share Price

49.70 0.63 1.28%
as on 12-Dec'24 16:59

DeciZen - make an informed investing decision on Kimia Biosciences

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Somewhat Undervalued

3. Price Trend

Kimia Biosciences stock performance -

mw4me loader
P/E Ratio (SA):
81.14
Market Cap:
235.1 Cr.
52-wk low:
33.2
52-wk high:
58.4

Is Kimia Biosciences Ltd an attractive stock to invest in?

1. Is Kimia Biosciences Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Kimia Biosciences Ltd is a below average quality company.

2. Is Kimia Biosciences Ltd undervalued or overvalued?

The key valuation ratios of Kimia Biosciences Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Kimia Biosciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Kimia Biosciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Kimia Biosciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Kimia Biosciences Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % -23.9%-135.8%-216.8%-18.3%11.8%16.9%8.9%16.1%-2.3%-14.3%-
Value Creation
Index
-2.7-10.7NANA-0.20.2-0.40.2-1.2-2.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 6.51.80.21.576.393.9106133125129107
Sales YoY Gr.--72.9%-89.1%668.4%5,126.7%23.1%13.2%24.9%-5.9%2.9%-
Adj EPS -1.1-2.3-5.4-1.70.92.70.40.9-0.8-1.60.6
YoY Gr.-NANANANA189.4%-85.7%125.6%-194.3%NA-
BVPS (₹) 2.50.2-5.3-6.3-0.22.42.93.93.21.20.7
Adj Net
Profit
-0.8-1.7-4-1.21.441.84.2-3.9-7.63
Cash Flow from Ops. 0.60-6-0.7-7.1-2.70.368-6.8-
Debt/CF from Ops. 0.44.6-1.1-13.2-4.2-11.61107.55.1-7.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 39.4%11%6.5%2.9%
Adj EPS NA-211.4%-260.4%NA
BVPS-8.4%NA-26.2%-63.5%
Share Price - 18.1% 7.4% 32.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
-34.6-166.1215.129-117.594.718.526.2-23.6-74.766.7
Op. Profit
Mgn %
-5-109.8-1690-56.53.26.14.86.30.5-2.89.5
Net Profit
Mgn %
-12.2-97.5-2074.2-84.51.84.21.73.1-3.1-5.92.7
Debt to
Equity
0.11-1.7-2.191.27.42.52.42.79.75.3
Working Cap
Days
1072961,99635410217018417920722195
Cash Conv.
Cycle
12-842455458493888890-11

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 66.70%

Sales growth has been subdued in last 3 years 6.54%

Net Profit has been subdued in last 3 years -260.42%

Debt to equity has increased versus last 3 years average to 9.69

Sales growth is not so good in last 4 quarters at 8.35%

Latest Financials - Kimia Biosciences Ltd.

Standalone Consolidated
TTM EPS (₹) 0.6 -
TTM Sales (₹ Cr.) 107 -
BVPS (₹.) 0.7 -
Reserves (₹ Cr.) -2 -
P/BV 73.28 -
PE 81.14 -
From the Market
52 Week Low / High (₹) 33.20 / 58.40
All Time Low / High (₹) 0.60 / 76.50
Market Cap (₹ Cr.) 235
Equity (₹ Cr.) 4.7
Face Value (₹) 1
Industry PE 44

Management X-Ray of Kimia Biosciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Kimia Biosciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales62017694106133125129
Operating Expenses 74427488102124124134
Manufacturing Costs310034691011
Material Costs0100597180979296
Employee Cost 32218911141516
Other Costs 00114555710
Operating Profit 0-2-3-126481-5
Operating Profit Margin (%) -5.0%-109.0%-1,759.4%-67.2%3.2%5.9%4.2%6.3%0.5%-4.0%
Other Income 0101111211
Interest 0010123344
Depreciation 0000112233
Exceptional Items 000000000-1
Profit Before Tax -1-2-4-12416-5-12
Tax 00000000-1-3
Profit After Tax -1-2-4-12415-4-9
PAT Margin (%) -12.2%-97.5%-2,109.8%-63.7%2.2%4.1%1.3%3.8%-3.0%-7.3%
Adjusted EPS (₹)-1.1-2.3-5.5-1.31.12.60.31.1-0.8-2.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 20-4-5041318155
Share Capital 7777225555
Reserves -6-7-11-12-22914101
Minority Interest0000000000
Debt0079293031413951
Long Term Debt0079252424282431
Short Term Debt0000556131520
Trade Payables1100191827314047
Others Liabilities 331791415161415
Total Liabilities 65412586586107109117

Fixed Assets

Gross Block1212127151922344446
Accumulated Depreciation88802346912
Net Fixed Assets4337131618283534
CWIP 0003226601
Investments 0000000000
Inventories0001101620243748
Trade Receivables0000292937423031
Cash Equivalents 0000211210
Others Assets1111213564
Total Assets 65412586586107109117

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 10-6-1-7-3068-7
PBT -1-2-4-12416-5-12
Adjustment 1011114468
Changes in Working Capital 11-3-0-10-8-5-37-2
Tax Paid 0000000000
Cash Flow From Investing Activity 000-6-2-2-9-14-1-3
Capex 000-6-3-3-9-14-2-3
Net Investments 0000000010
Others 0000000000
Cash Flow From Financing Activity 006710488-810
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 007311434-37
Interest Paid 00-10-1-1-1-2-3-3
Dividend Paid 0000000000
Others 00040177-25
Net Cash Flow 0000000000
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)-34.59N/AN/AN/AN/A243.8316.4732.19-22.22-91.91
ROCE (%)-23.86N/AN/AN/AN/A16.948.9416.13-2.32-14.3
Asset Turnover Ratio1.120.340.040.182.181.521.411.381.161.14
PAT to CFO Conversion(x)N/AN/AN/AN/A-3.5-0.7501.2N/AN/A
Working Capital Days
Receivable Days5069346217111411410910586
Inventory Days615143832450636189121
Payable Days8976282,3912606195101108140165

Kimia Biosciences Ltd Stock News

Kimia Biosciences Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Kimia Biosciences on 12-Dec-2024 16:59 is ₹49.70.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 12-Dec-2024 16:59 the market cap of Kimia Biosciences stood at ₹235.1.
The latest P/E ratio of Kimia Biosciences as of 12-Dec-2024 16:59 is 81.14.
The latest P/B ratio of Kimia Biosciences as of 12-Dec-2024 16:59 is 73.28.
The 52-week high of Kimia Biosciences is ₹58.40 and the 52-week low is ₹33.20.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Kimia Biosciences is ₹107.0 ( Cr.) .

About Kimia Biosciences Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.